Your browser doesn't support javascript.
loading
Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience.
Gutierrez-Sainz, L; Martinez-Marin, V; Viñal, D; Martinez-Perez, D; Pedregosa, J; Garcia-Cuesta, J A; Villamayor, J; Zamora, P; Pinto, A; Redondo, A; Castelo, B; Cruz, P; Higuera, O; Custodio, A; Gallego, A; Sanchez-Cabrero, D; de Castro-Carpeño, J; Espinosa, E; Feliu, J.
Afiliação
  • Gutierrez-Sainz L; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain. laura.gutierrezsainz@gmail.com.
  • Martinez-Marin V; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Viñal D; Translational Oncology Group, IdiPAZ, Madrid, Spain.
  • Martinez-Perez D; Cancer & Thrombosis Section, Spanish Society of Medical Oncology (SEOM), Madrid, Spain.
  • Pedregosa J; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Garcia-Cuesta JA; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Villamayor J; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Zamora P; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Pinto A; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Redondo A; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Castelo B; Translational Oncology Group, IdiPAZ, Madrid, Spain.
  • Cruz P; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Higuera O; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Custodio A; Translational Oncology Group, IdiPAZ, Madrid, Spain.
  • Gallego A; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
  • Sanchez-Cabrero D; Translational Oncology Group, IdiPAZ, Madrid, Spain.
  • de Castro-Carpeño J; Faculty of Medicine, Universidad Autónoma de Madrid, Madrid, Spain.
  • Espinosa E; Cátedra UAM-AMGEN, Madrid, Spain.
  • Feliu J; Medical Oncology Department, Hospital Universitario La Paz, IdiPAZ, Paseo de la Castellana 261, Madrid, 28046, Spain.
Clin Transl Oncol ; 23(6): 1245-1252, 2021 Jun.
Article em En | MEDLINE | ID: mdl-33231859
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Imunoterapia / Neoplasias Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha País de publicação: Itália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa / Imunoterapia / Neoplasias Tipo de estudo: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Transl Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha País de publicação: Itália